Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimod.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Generation of Monoclonal Autoantibodies From Myelin Oligodendrocyte Glycoprotein-Specific Human B Cells Using an Optofluidic-Based Platform.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Research square·2026
Same author

IgG4 on the dance floor: Partners swapped by Fab-arm exchange.

Science immunology·2026
Same author

IgA autoantibodies demonstrate a novel mechanism of MuSK myasthenia gravis pathology.

Brain : a journal of neurology·2025
Same author

Screening for Congenital Myasthenic Syndromes in Adults With Seronegative Myasthenia Gravis Using Next-Generation Sequencing.

Neurology·2025

Related Experiment Video

Updated: Jun 24, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.3K

Hide-&-Go-PhiP-Seq: Finding an elusive predictive MS biomarker.

Annabel Wallace1, Kevin C O'Connor1

  • 1Departments of Neurology and Immunobiology, Yale University School of Medicine, New Haven, CT, USA.

Science Immunology
|June 7, 2024
PubMed
Summary
This summary is machine-generated.

Researchers identified a unique immune system pattern, or autoantibody signature, that appears before the symptoms of multiple sclerosis (MS) emerge. This discovery offers potential for early MS detection.

More Related Videos

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.8K
Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
00:07

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019

8.3K

Related Experiment Videos

Last Updated: Jun 24, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.3K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.8K
Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
00:07

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019

8.3K

Area of Science:

  • Immunology
  • Neurology
  • Proteomics

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Early detection of MS is challenging due to its variable clinical presentation and the often-late onset of symptoms.

Purpose of the Study:

  • To investigate if an autoantibody signature detectable through whole-proteome profiling can predict the clinical onset of multiple sclerosis.

Main Methods:

  • Utilized whole-proteome autoantibody profiling to analyze immune responses.
  • Compared autoantibody profiles in individuals before and after the clinical diagnosis of MS.

Main Results:

  • Identified a distinct immunological signature characterized by specific autoantibodies.
  • This signature was found to precede the clinical manifestation of multiple sclerosis.

Conclusions:

  • Whole-proteome autoantibody profiling can reveal an immunological signature associated with multiple sclerosis.
  • This signature has the potential to serve as an early biomarker for predicting MS onset.